CONDENSED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Sales, net	$ 8,295,173	$ 7,599,363
Cost of sales:
Total cost of sales	8,297,084	5,698,434
Gross profit (loss)	(1,911)	1,900,929
Operating expenses:
Sales and marketing	1,601,808	1,434,742
Research and development	191,192	142,262
General and administrative	2,881,841	3,310,062
Total operating expenses	4,674,841	4,887,066
Loss from operations	(4,676,752)	(2,986,137)
Other income - TIA	1,482,819	1,484,620
Unrealized gain (loss) on debt and equity securities	(7,156,513)	1,732,649
Interest and other income	158,946	317,321
Interest expense	(23,455)	(33,483)
Income (loss) before income taxes	(10,214,955)	514,970
Provision for income taxes	285,761	85,586
Net income (loss)	(10,500,716)	429,384
Preferred Stock dividend requirements	(57,611)	(57,611)
Net income (loss) applicable to common shareholders	$ (10,558,327)	$ 371,773
Basic earnings (loss) per share	$ (0.35)	$ 0.01
Diluted earnings (loss) per share	$ (0.35)	$ 0.01
Weighted average common shares outstanding:
Basic (in shares)	29,937,159	29,937,159
Diluted (in shares)	29,937,159	29,945,353
Cost of manufactured product
Cost of sales:
Total cost of sales	$ 7,590,663	$ 5,049,046
Royalty expense to shareholder
Cost of sales:
Total cost of sales	$ 706,421	$ 649,388